Quantum Dot Diagnostics: Simultaneous Genomic and Proteomic Profiling of Multiple Pathogens at Point-of-Care: GE3LS Program

Overview

The goal of this program and the three projects outlined below is to systematically address the potential GE3LS issues stemming from the development and commercialization of the quantum dot (Qdot) diagnostic system based on genomic and proteomic profiling of infectious agents.

Project Objectives

1. To design public engagement tools on the GE3LS of convergent technologies:
   MalariaEngage is a platform that will support the development of a global community of scientists, organizations, businesses, youth and activists committed to eradicating malaria.  Both engagement platforms aim mainly to increase the awareness of young people, and provide opportunities for them to take action. WaterEngage is a similar an internet-based youth engagement module geared toward exploring the potential for nanotechnology and biotechnology applications to help deliver safe drinking water to communities throughout the world. 
2. To regulate convergence of Genomics, Proteomics and Nanotechnology Research: The objective of this project is to identify regulatory issues related to convergent technologies and work with Canadian regulatory authorities to develop regimes and guidelines on implementation of any standards that may be developed.
3. To monitor of risks and benefits of Quantum Dots:
   The objective of this project is to develop a Q-Dot Toxicology Database of research publications and data on the potential risks of Qdots after exposure. We will then help to develop and formulate policy and Canadian standards on the development and use of quantum dots technology.